TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Nonfarm Payrolls (September)
IMTX

Immatics NV

Healthcare · Biotechnology

8.80$ +2.6% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Balance Sheet

Immatics NV (IMTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 486 million EUR. Tick rows to compare them in a chart.

All figures in millions of EUR.

Tick rows to compare them in a chart (up to 4)

Balance Sheet IMTX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
437 510 653 627 577 696 642 567 519 562 544 486
385 449 588 559 513 630 574 504 458 504 485 429
83 218 122 158 189 237 243 257 335 346 302 232
366 426 564 531 491 604 544 478 431 469 454 393
1.4 5.7 3.4 3.6 8.4 6.7 6.6 2.9 4.3 6.9 4.8 6.7
11 11 0.0 0.0 – – – – – – – –
1.6 1.5 1.5 1.6 1.6 1.6 1.6 1.6 1.6 1.6 1.6 1.6
190 292 252 239 195 121 105 103 102 78 88 86
121 157 149 150 129 68 56 57 62 43 55 57
2.8 2.6 2.8 3.2 2.8 2.9 3.0 3.0 2.9 2.8 2.6 2.7
6.2 7.7 6.1 3.8 8.9 10 5.9 4.2 2.8 0.3 8.1 6.2
248 218 401 388 383 575 537 465 417 484 456 399
-571 -605 -600 -618 -627 -590 -629 -700 -750 -786 -845 -906
83 85 106 103 110 107 122 122 122 126 135 137

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?